Dapagliflozin Sitagliptin-Preferred SGLT2i-DPP4i FDC in Indian Clinical Practice Dr. Saptarshi Bhattacharya7 April 2025 11:34 AM ISTType 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals affected and 39.4 million...
Indian CV Risk Factors and Emerging Evidence for Aspirin in Primary Prevention- What's New? Dr. Jay Shah5 April 2025 11:32 AM ISTCardiovascular diseases (CVDs) remain the leading cause of mortality and disability in India, contributing to 31.8% of deaths. Noncommunicable...
Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid Peptic Disorders Dr. Kamal Kant Kohli26 March 2025 11:36 AM ISTThe Association of Physicians of India (API) has recently issued a consensus statement, highlighting vonoprazan as an effective option for managing...
Brief Review on Vitamin D Formulations: Spotlight on Nanoemulsion and Its Innovations Dr. Kamal Kant Kohli18 March 2025 10:52 AM ISTDeficiency and insufficiency of vitamin D is a global concern, affecting a vast proportion of the Indian population as well; with reportedly 85%...
Prediabetes and Associated Risk in Young Adults - Alopecia Areata and Erectile Dysfunction Dr Anshul Agrawal13 March 2025 12:23 PM ISTThe rising prevalence of prediabetes among young adults signals early metabolic dysfunction, significantly increasing the risk of type 2 diabetes...
Lipoprotein(a), ASCVD risk, and Aspirin- What is the Latest Evidence Saying? Dr. Roopali Khanna7 Feb 2025 12:21 PM ISTLipoprotein (a) [Lp(a)] is considered pro-atherosclerotic, pro-inflammatory, pro-thrombotic, and anti-fibrinolytic. Lipoprotein(a) levels >50 mg/dL...
Metoprolol in Coronary Artery Disease: Top 5 Evidence Insights Dr. S. N. Routray6 Feb 2025 11:41 AM ISTCoronary Artery Disease-A Concerning Epidemiology in India:India has the highest burden of acute coronary syndrome and ST-elevation myocardial...
Ibuprofen-Paracetamol Combination-Where Does it Stand in 2025? Dr. Kamal Kant Kohli27 Jan 2025 12:00 PM ISTThe ibuprofen-paracetamol combination remains a cornerstone in pain management in 2025, offering synergistic efficacy and acceptable safety profiles....
Addressing Pneumococcal Disease in CKD Patients: A Call for Preventive Action Dr. Alan Almeida22 Jan 2025 11:49 AM ISTIn India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies reporting a prevalence...
Intranasal Corticosteroids in Allergic Rhinitis: Indian ENT Perspective and Utility of Fluticasone Furoate Dr. Kamal Kant Kohli3 Jan 2025 11:00 AM ISTAllergic Rhinitis (AR), one of the most prevalent types of chronic rhinitis, has marked symptoms of nasal congestion, itching, rhinorrhoea, sneezing,...
PCOS Management in India in 2024: Top 10 Insights from Gynecologists, Dermatologists and Endocrinologists Cross-Talk Dr. Kamal Kant Kohli11 Dec 2024 11:45 AM ISTPolycystic Ovary Syndrome (PCOS) remains one of the most challenging health concerns for women in India today, impacting both physical and emotional...
A Comparative Analysis: Selenium Sulfide vs Ketoconazole in Seborrheic Dermatitis and Dandruff Dr. Kamal Kant Kohli9 Dec 2024 9:15 AM ISTSeborrheic dermatitis is a prevalent inflammatory skin condition characterized by papulosquamous lesions, primarily affecting areas abundant in...
